Form 4: Abbott Director Acquires Stock Equivalent Units
Insider Transaction Report
Abbott Laboratories Director Michael F. Roman acquired 301 stock equivalent units, increasing his beneficial ownership to 5,882 units.
Summary
- Michael F. Roman, a Director at Abbott Laboratories (ABT), acquired 301 stock equivalent units.
- The transaction took place on December 31, 2025.
- The acquisition price for these units was $125.29 per unit.
- Following this transaction, Roman's total beneficial ownership of stock equivalent units stands at 5,882.
- These stock equivalent units represent director fees and are generally paid out in cash when the director reaches age 65 or retires from the board.
- The units are structured to provide the same return as if the director's fees were directly invested in Abbott shares.
- The reported balance of 5,882 units includes those accumulated through a dividend reinvestment feature.
Sentiment
Score: 6
Explanation: The acquisition of stock equivalent units by a director is generally a positive signal, indicating alignment of interests and confidence in the company's future performance. However, as a routine compensation-related transaction, its direct impact on sentiment is moderate.
Positives
- Director Michael F. Roman increased his beneficial ownership by acquiring 301 stock equivalent units, signaling continued confidence in the company.
- The design of the stock equivalent units aligns the director's financial interests with those of common shareholders, as they mirror the return of Abbott shares.
Future Outlook
The stock equivalent units are generally paid out in cash upon the director reaching age 65 or retiring from the board, indicating a long-term incentive structure.
Management Comments
- Director fees are credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.
- The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
Industry Context
This is a routine insider transaction report, common across all publicly traded companies, reflecting a director's compensation structure and personal investment activity in the company's equity.
Related Party Transactions
- Director fees are credited to a stock equivalent unit account, representing compensation for services rendered by a related party (Director Michael F. Roman).
Stakeholder Impact
- Shareholders: Increased director ownership aligns management's interests more closely with those of shareholders, potentially fostering long-term value creation.
Next Steps
- Payment of stock equivalent units in cash, generally at age 65 or upon retirement from the board.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Date of acquisition of 301 stock equivalent units by Director Michael F. Roman. |
| 01/05/2026 | Date the Form 4 was signed by Michael F. Roman via Attorney-in-Fact Jessica H. Paik. |
Keywords
Abbott Laboratories, ABT, Form 4, Insider Transaction, Stock Equivalent Units, Director Ownership, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.